Directed genetic modification of African horse sickness virus by reverse genetics

African horse sickness virus (AHSV), a member of the Orbivirus genus in the family Reoviridae, is an arthropod-transmitted pathogen that causes a devastating disease in horses with a mortality rate greater than 90%. Fundamental research on AHSV and the development of safe, efficacious vaccines could benefit greatly from an uncomplicated genetic modification method to generate recombinant AHSV. We demonstrate that infectious AHSV can be recovered by transfection of permissive mammalian cells with transcripts derived in vitro from purified AHSV core particles. These findings were expanded to establish a genetic modification system for AHSV that is based on transfection of the cells with a mixture of purified core transcripts and a synthetic T7 transcript. This approach was applied successfully to recover a directed cross-serotype reassortant AHSV and to introduce a marker sequence into the viral genome. The ability to manipulate the AHSV genome and engineer specific mutants will increase understanding of AHSV replication and pathogenicity, as well as provide a tool for generating designer vaccine strains.

Saved in:
Bibliographic Details
Main Authors: Vermaak,Elaine, Paterson,Duncan J., Conradie,Andele, Theron,Jacques
Format: Digital revista
Language:English
Published: Academy of Science of South Africa 2015
Online Access:http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0038-23532015000400020
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0038-23532015000400020
record_format ojs
spelling oai:scielo:S0038-235320150004000202015-08-13Directed genetic modification of African horse sickness virus by reverse geneticsVermaak,ElainePaterson,Duncan J.Conradie,AndeleTheron,Jacques orbivirus core transcripts genome modification vaccine African horse sickness virus (AHSV), a member of the Orbivirus genus in the family Reoviridae, is an arthropod-transmitted pathogen that causes a devastating disease in horses with a mortality rate greater than 90%. Fundamental research on AHSV and the development of safe, efficacious vaccines could benefit greatly from an uncomplicated genetic modification method to generate recombinant AHSV. We demonstrate that infectious AHSV can be recovered by transfection of permissive mammalian cells with transcripts derived in vitro from purified AHSV core particles. These findings were expanded to establish a genetic modification system for AHSV that is based on transfection of the cells with a mixture of purified core transcripts and a synthetic T7 transcript. This approach was applied successfully to recover a directed cross-serotype reassortant AHSV and to introduce a marker sequence into the viral genome. The ability to manipulate the AHSV genome and engineer specific mutants will increase understanding of AHSV replication and pathogenicity, as well as provide a tool for generating designer vaccine strains.Academy of Science of South AfricaSouth African Journal of Science v.111 n.7-8 20152015-08-01journal articletext/htmlhttp://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0038-23532015000400020en
institution SCIELO
collection OJS
country Sudáfrica
countrycode ZA
component Revista
access En linea
databasecode rev-scielo-za
tag revista
region África del Sur
libraryname SciELO
language English
format Digital
author Vermaak,Elaine
Paterson,Duncan J.
Conradie,Andele
Theron,Jacques
spellingShingle Vermaak,Elaine
Paterson,Duncan J.
Conradie,Andele
Theron,Jacques
Directed genetic modification of African horse sickness virus by reverse genetics
author_facet Vermaak,Elaine
Paterson,Duncan J.
Conradie,Andele
Theron,Jacques
author_sort Vermaak,Elaine
title Directed genetic modification of African horse sickness virus by reverse genetics
title_short Directed genetic modification of African horse sickness virus by reverse genetics
title_full Directed genetic modification of African horse sickness virus by reverse genetics
title_fullStr Directed genetic modification of African horse sickness virus by reverse genetics
title_full_unstemmed Directed genetic modification of African horse sickness virus by reverse genetics
title_sort directed genetic modification of african horse sickness virus by reverse genetics
description African horse sickness virus (AHSV), a member of the Orbivirus genus in the family Reoviridae, is an arthropod-transmitted pathogen that causes a devastating disease in horses with a mortality rate greater than 90%. Fundamental research on AHSV and the development of safe, efficacious vaccines could benefit greatly from an uncomplicated genetic modification method to generate recombinant AHSV. We demonstrate that infectious AHSV can be recovered by transfection of permissive mammalian cells with transcripts derived in vitro from purified AHSV core particles. These findings were expanded to establish a genetic modification system for AHSV that is based on transfection of the cells with a mixture of purified core transcripts and a synthetic T7 transcript. This approach was applied successfully to recover a directed cross-serotype reassortant AHSV and to introduce a marker sequence into the viral genome. The ability to manipulate the AHSV genome and engineer specific mutants will increase understanding of AHSV replication and pathogenicity, as well as provide a tool for generating designer vaccine strains.
publisher Academy of Science of South Africa
publishDate 2015
url http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0038-23532015000400020
work_keys_str_mv AT vermaakelaine directedgeneticmodificationofafricanhorsesicknessvirusbyreversegenetics
AT patersonduncanj directedgeneticmodificationofafricanhorsesicknessvirusbyreversegenetics
AT conradieandele directedgeneticmodificationofafricanhorsesicknessvirusbyreversegenetics
AT theronjacques directedgeneticmodificationofafricanhorsesicknessvirusbyreversegenetics
_version_ 1756004809903702016